iX Biopharma Signs Exclusive License Agreement For Wafermine A...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SINGAPORE, Nov. 25, 2021 /PRNewswire-Asianet/ -- - iX Biopharma will receive an initial US$9 million upfront payment - Eligible for up to US$239 million in development and sales milestone payments - Double digit royalties on future product sales of any licensed productiX Biopharma Ltd (S...
Authors: LATEST ASIANET NEWS RELEASES